These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 16640037)

  • 1. Allogeneic related bone marrow transplantation in children--a single center experience.
    Chen SH; Hung IJ; Yang CP; Jaing TH; Fang EC; Yang SH; Tseng CK
    Acta Paediatr Taiwan; 2005; 46(6):352-5. PubMed ID: 16640037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation.
    Gordon BG; Warkentin PI; Strandjord SE; Abromowitch M; Bayever E; Harper JL; Coccia PF
    Bone Marrow Transplant; 1997 Jul; 20(1):5-10. PubMed ID: 9232249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic peripheral blood stem cell transplantations in children--a single center experience.
    Sufliarska S; Horáková J; Bodová I; Martinka J; Hrubisko M; Kovács L; Jancovicová K; Lukác J
    Neoplasma; 2004; 51(2):110-6. PubMed ID: 15190420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preliminary study of HLA haplotype matched and T-cell undepleted allogeneic bone marrow transplantation for treatment of leukemia].
    Ji S; Chen H; Wang H
    Zhonghua Xue Ye Xue Za Zhi; 2001 Aug; 22(8):408-10. PubMed ID: 11718090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
    Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic bone marrow transplantation from partially mismatched related donors as therapy for primary induction failure acute myeloid leukemia.
    Chiang KY; Van Rhee F; Godder K; Bridges K; Adams S; Mehta J; Henslee-Downey PJ
    Bone Marrow Transplant; 2001 Mar; 27(5):507-10. PubMed ID: 11313684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infused CD34+ cell dose predicts long-term survival in acute myelogenous leukemia patients who received allogeneic bone marrow transplantation from matched sibling donors in first complete remission.
    Lee SH; Lee MH; Lee JH; Min YH; Lee KH; Cheong JW; Lee J; Park KW; Kang JH; Kim K; Kim WS; Jung CW; Choi SJ; Lee JH; Park K
    Biol Blood Marrow Transplant; 2005 Feb; 11(2):122-8. PubMed ID: 15682073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia].
    Tong XZ; Li J; Tan EX; Zhang GC; Wu XY; Peng AH; Zheng D; Zou WY; Hong WD; Luo SK
    Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):545-8. PubMed ID: 17147125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early deaths in children after BMT. Bone Marrow Transplantation Group of the Italian Association for Pediatric Hematology and Oncology (AIEOP) and Gruppo Italiano Trapianto di Midollo Osseo (GITMO).
    Garaventa A; Porta F; Rondelli R; Dini G; Meloni G; Bonetti F; Uderzo C; De Manzini A; Miniero R; Brutti F
    Bone Marrow Transplant; 1992 Nov; 10(5):419-23. PubMed ID: 1464003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unrelated-donor bone marrow transplantation for Philadelphia chromosome-positive chronic myelogenous leukemia in children: experience of eight European Countries. The EBMT Paediatric Diseases Working Party.
    Dini G; Rondelli R; Miano M; Vossen J; Gluckman E; Peters C; Bordigoni P; Locatelli F; Miniero R; Ljungman P; Saarinen U; Klingebiel T; Ortega J; Lanino E
    Bone Marrow Transplant; 1996 Nov; 18 Suppl 2():80-5. PubMed ID: 8932805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of relapsed acute leukemia after allogeneic transplantation: a single center experience.
    Arellano ML; Langston A; Winton E; Flowers CR; Waller EK
    Biol Blood Marrow Transplant; 2007 Jan; 13(1):116-23. PubMed ID: 17222760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High frequency of extramedullary relapse of acute leukemia after allogeneic bone marrow transplantation.
    Lee KH; Lee JH; Kim S; Lee JS; Kim SH; Kim WK
    Bone Marrow Transplant; 2000 Jul; 26(2):147-52. PubMed ID: 10918424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of relapsed acute lymphoblastic leukemia after allogeneic bone marrow transplantation with chemotherapy followed by G-CSF-primed donor leukocyte infusion: a prospective study.
    Choi SJ; Lee JH; Lee JH; Kim S; Lee YS; Seol M; Ryu SG; Lee JS; Kim WK; Jang S; Park CJ; Chi HS; Lee KH
    Bone Marrow Transplant; 2005 Jul; 36(2):163-9. PubMed ID: 15937507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long term disease-free survival in acute leukemia patients recovering with increased gammadelta T cells after partially mismatched related donor bone marrow transplantation.
    Godder KT; Henslee-Downey PJ; Mehta J; Park BS; Chiang KY; Abhyankar S; Lamb LS
    Bone Marrow Transplant; 2007 Jun; 39(12):751-7. PubMed ID: 17450185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poor outcome in children with refractory/relapsed leukemia undergoing bone marrow transplantation with mismatched family member donors.
    Goldman FD; Rumelhart SL; DeAlacron P; Holida MD; Lee NF; Miller J; Trigg M; Giller R
    Bone Marrow Transplant; 2000 May; 25(9):943-8. PubMed ID: 10800061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of cyclosporin A on acute graft-versus-host disease after allogeneic bone marrow transplantation in children and adolescents with acute lymphoblastic leukemia.
    Teuffel O; Schrauder A; Sykora KW; Zimmermann M; Reiter A; Welte K; Schrappe M
    Bone Marrow Transplant; 2005 Jul; 36(2):145-50. PubMed ID: 15908976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ABO blood group barrier in allogeneic bone marrow transplantation revisited.
    Seebach JD; Stussi G; Passweg JR; Loberiza FR; Gajewski JL; Keating A; Goerner M; Rowlings PA; Tiberghien P; Elfenbein GJ; Gale RP; van Rood JJ; Reddy V; Gluckman E; Bolwell BJ; Klumpp TR; Horowitz MM; Ringdén O; Barrett AJ;
    Biol Blood Marrow Transplant; 2005 Dec; 11(12):1006-13. PubMed ID: 16338623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Excellent outcome of allogeneic hematopoietic stem cell transplantation using a conditioning regimen with medium-dose VP-16, cyclophosphamide and total-body irradiation for adult patients with acute lymphoblastic leukemia.
    Shigematsu A; Kondo T; Yamamoto S; Sugita J; Onozawa M; Kahata K; Endo T; Shiratori S; Ota S; Obara M; Wakasa K; Takahata M; Takeda Y; Tanaka J; Hashino S; Nishio M; Koike T; Asaka M; Imamura M
    Biol Blood Marrow Transplant; 2008 May; 14(5):568-75. PubMed ID: 18410899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic bone marrow transplantation in children failing prior autologous bone marrow transplantation.
    Hale GA; Tong X; Benaim E; Cunningham JM; Heslop HE; Horwiz EM; Leung W; Rochester RJ; Shearer PD; Srivastava DK; Woodard JP; Bowman LC
    Bone Marrow Transplant; 2001 Jan; 27(2):155-62. PubMed ID: 11281384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous bone marrow mixed with HLA-haploidentical allogeneic marrow transplantation for treatment of patients with malignant blood diseases.
    Da WM; Liu Y; Zhong JT; Bai H; Ji MJ; Wang CB; Lu JZ; Chen JM; Wang YL; Wu XX; Xu SF; Zhang Q; Wei YM
    Bone Marrow Transplant; 1997 Jan; 19(2):107-12. PubMed ID: 9116606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.